LKT Laboratories, Inc.

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Abacavir Sulfate 5 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Abacavir Sulfate 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Abacavir Sulfate 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Abacavir Sulfate 50 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Abamectin 5 g  | ≥95%

LKT Laboratories, Inc.

Macrocyclic lactone avermectin; GABA antagonist, F0F1-ATPase and adenine nucleotide translocator inhibitor.

More Information Supplier Page

×

Abamectin

Abamectin 5 g  | ≥70%

LKT Laboratories, Inc.

Macrocyclic lactone avermectin; GABA antagonist, F0F1-ATPase and adenine nucleotide translocator inhibitor.

More Information Supplier Page

×

Abamectin

Abamectin 25 g  | ≥70%

LKT Laboratories, Inc.

Macrocyclic lactone avermectin; GABA antagonist, F0F1-ATPase and adenine nucleotide translocator inhibitor.

More Information Supplier Page

×

Abamectin

Abiraterone 5 mg  | ≥98%

LKT Laboratories, Inc.

Progesterone derivative; Cyp17A1 inhibitor.

More Information Supplier Page

×

Abiraterone

Abiraterone 25 mg  | ≥98%

LKT Laboratories, Inc.

Progesterone derivative; Cyp17A1 inhibitor.

More Information Supplier Page

×

Abiraterone

Abiraterone 100 mg  | ≥98%

LKT Laboratories, Inc.

Progesterone derivative; Cyp17A1 inhibitor.

More Information Supplier Page

×

Abiraterone

ABT-199 5 mg  | ≥98%

LKT Laboratories, Inc.

BH3 mimetic; Bcl-2 inhibitor.

More Information Supplier Page

×

ABT-199

ABT-199 5 mg  | ≥98%

LKT Laboratories, Inc.

BH3 mimetic; Bcl-2 inhibitor.

More Information Supplier Page

×

ABT-199

ABT-199 10 mg  | ≥98%

LKT Laboratories, Inc.

BH3 mimetic; Bcl-2 inhibitor.

More Information Supplier Page

×

ABT-199

ABT-263 5 mg  | ≥98%

LKT Laboratories, Inc.

BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.

More Information Supplier Page

×

ABT-263

ABT-263 5 mg  | ≥98%

LKT Laboratories, Inc.

BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.

More Information Supplier Page

×

ABT-263

ABT-263 10 mg  | ≥98%

LKT Laboratories, Inc.

BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.

More Information Supplier Page

×

ABT-263

Ac-D-E 5 mg  | ≥95%

LKT Laboratories, Inc.

Mast cell stabilizer.

More Information Supplier Page

×

Ac-D-E

Ac-D-E 10 mg  | ≥95%

LKT Laboratories, Inc.

Mast cell stabilizer.

More Information Supplier Page

×

Ac-D-E

Ac-D-E 25 mg  | ≥95%

LKT Laboratories, Inc.

Mast cell stabilizer.

More Information Supplier Page

×

Ac-D-E

Ac-DEVD-pNA 5 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 3 substrate.

More Information Supplier Page

×

Ac-DEVD-pNA

Ac-DEVD-pNA 2 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 3 substrate.

More Information Supplier Page

×

Ac-DEVD-pNA

Ac-DEVD-pNA 5 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 3 substrate.

More Information Supplier Page

×

Ac-DEVD-pNA

Ac-GPK-pNA 25 mg  | ≥95%

LKT Laboratories, Inc.

Caspase substrate.

More Information Supplier Page

×

Ac-GPK-pNA

Ac-GPK(Ac)-pNA 25 mg  | ≥95%

LKT Laboratories, Inc.

Caspase substrate.

More Information Supplier Page

×

Ac-GPK(Ac)-pNA

Ac-IEAR-pNA 25 mg  | ≥95%

LKT Laboratories, Inc.

Caspase substrate.

More Information Supplier Page

×

Ac-IEAR-pNA

Ac-IETD-pNA 25 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 8 substrate.

More Information Supplier Page

×

Ac-IETD-pNA

Ac-LEHD-pNa 1 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 9 substrate.

More Information Supplier Page

×

Ac-LEHD-pNa

Ac-LEHD-pNa 2 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 9 substrate.

More Information Supplier Page

×

Ac-LEHD-pNa

Ac-LEHD-pNa 5 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 9 substrate.

More Information Supplier Page

×

Ac-LEHD-pNa

Ac-SDKP 5 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, degradation product of thymosin B4, involved in hematopoiesis.

More Information Supplier Page

×

Ac-SDKP

Ac-SDKP 10 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, degradation product of thymosin B4, involved in hematopoiesis.

More Information Supplier Page

×

Ac-SDKP

Ac-SDKP 25 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, degradation product of thymosin B4, involved in hematopoiesis.

More Information Supplier Page

×

Ac-SDKP

Ac-VEID-pNA 25 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 6 substrate.

More Information Supplier Page

×

Ac-VEID-pNA

Ac-YVAD-pNA 5 mg  | ≥95%

LKT Laboratories, Inc.

Caspase 1 substrate.

More Information Supplier Page

×

Ac-YVAD-pNA

Acarbose 1 g  | ≥98%

LKT Laboratories, Inc.

α-glucosidase inhibitor.

More Information Supplier Page

×

Acarbose

Acarbose 5 g  | ≥98%

LKT Laboratories, Inc.

α-glucosidase inhibitor.

More Information Supplier Page

×

Acarbose

Acarbose 25 g  | ≥98%

LKT Laboratories, Inc.

α-glucosidase inhibitor.

More Information Supplier Page

×

Acarbose

Aceclofenac 1 g  | ≥98%

LKT Laboratories, Inc.

Diclofenac analog, NSAID; COX-2 inhibitor.

More Information Supplier Page

×

Aceclofenac

Aceclofenac 5 g  | ≥98%

LKT Laboratories, Inc.

Diclofenac analog, NSAID; COX-2 inhibitor.

More Information Supplier Page

×

Aceclofenac

Aceclofenac 25 g  | ≥98%

LKT Laboratories, Inc.

Diclofenac analog, NSAID; COX-2 inhibitor.

More Information Supplier Page

×

Aceclofenac

Aceclofenac 100 g  | ≥98%

LKT Laboratories, Inc.

Diclofenac analog, NSAID; COX-2 inhibitor.

More Information Supplier Page

×

Aceclofenac

Acemetacin 1 g  | ≥98%

LKT Laboratories, Inc.

Glycolic acid ester prodrug of indomethacin, NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Acemetacin

Acemetacin 5 g  | ≥98%

LKT Laboratories, Inc.

Glycolic acid ester prodrug of indomethacin, NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Acemetacin

Acepromazine Maleate 25 mg  | ≥98%

LKT Laboratories, Inc.

Phenothiazine derivative; D1/2 and 5-HT1A/2A antagonist.

More Information Supplier Page

×

Acepromazine Maleate

Acepromazine Maleate 100 mg  | ≥98%

LKT Laboratories, Inc.

Phenothiazine derivative; D1/2 and 5-HT1A/2A antagonist.

More Information Supplier Page

×

Acepromazine Maleate

Acepromazine Maleate 250 mg  | ≥98%

LKT Laboratories, Inc.

Phenothiazine derivative; D1/2 and 5-HT1A/2A antagonist.

More Information Supplier Page

×

Acepromazine Maleate

Acetyl-L-Carnitine 1 g  | ≥98%

LKT Laboratories, Inc.

Natural carnitine derivative, involved in energy homeostasis.

More Information Supplier Page

×

Acetyl-L-Carnitine

Acetyl-L-Carnitine 5 g  | ≥98%

LKT Laboratories, Inc.

Natural carnitine derivative, involved in energy homeostasis.

More Information Supplier Page

×

Acetyl-L-Carnitine

Acetyl-L-Carnitine Hydrochloride 1 g  | ≥98%

LKT Laboratories, Inc.

Carnitine derivative, involved in energy homeostasis.

More Information Supplier Page

×

Acetyl-L-Carnitine Hydrochloride

Acetyl-L-Carnitine Hydrochloride 5 g  | ≥98%

LKT Laboratories, Inc.

Carnitine derivative, involved in energy homeostasis.

More Information Supplier Page

×

Acetyl-L-Carnitine Hydrochloride